Visual Loss After Filler: Recognising It and Referring Fast
Visual loss after dermal filler is an embolic emergency. The patient usually notices it at once, as pain, a change in vision or both, at the moment of injection or within seconds. Treat that report as the finding and start the referral immediately.
Minutes count, because the retina tolerates complete arterial obstruction only briefly, and outcomes are poor even when the response is fast. What you can control is arranged before the appointment: a named ophthalmic service, a person who makes the call, and a written handover with the product, site and timings.
Filler reaches the eye by travelling against arterial flow
The mechanism is embolic and retrograde. Filler introduced under pressure into a facial artery can travel against normal flow, reach the ophthalmic circulation and lodge in the retinal or posterior ciliary supply. The connections that allow this are ordinary anatomy present in every face, so the risk belongs to the region, not to an unlucky patient.
Reviews of the world literature agree on where it happens. The 2015 review placed the glabella first and the nose second [6]. In the 2019 update the nose came first, followed by the glabella, the forehead and the nasolabial fold [1]. A systematic review of case reports and series found the same clustering, and most patients had immediate rather than delayed visual symptoms [2]. The same few regions stayed at the top in both reviews, although hyaluronic acid replaced fat as the commonest filler [1][6]. That points to anatomy rather than to who happened to report.
All of this comes from case reports and small series. Under-reporting is near-certain when the injector is often the only clinician involved, so any frequency drawn from this literature is a floor, not a rate.
The retinal window is measured in minutes
Work in rhesus monkeys, done long before cosmetic filler, found that the retina recovered well after 97 minutes of complete central retinal artery occlusion but was irreparably damaged after 105 minutes [3]. That occlusion was experimental and complete. A filler embolus is not reliably either, so treat the window as an order of magnitude, not a deadline to work to.
Acting inside the window does not promise that vision returns. It tells you that outside it, nothing will. Reported outcomes are poor even after a fast response, and any protocol that promises recovery claims more than the literature supports [1][2].
The foreseeable delays come from coordination, not technique
Three failures are easy to foresee, though the case reports rarely record them. The practitioner may wait several minutes before acting on what the patient said, because the first instinct is to inspect the skin rather than believe the report. The referral may then go to a general emergency department instead of ophthalmology. And it may arrive without what changes the receiving clinician's assessment: what was injected, where and when.
A fourth factor is harder to admit. The practitioner caused the injury, and the reflex to prove it cannot be happening is strong. Every minute spent on that is spent inside a closing window. A written pathway helps because it acts without first needing to believe anything.
Retrobulbar hyaluronidase is contested and belongs to specialists
A case series of four patients treated with retrobulbar hyaluronidase after hyaluronic acid embolisation found no improvement in vision in any of them, although every patient was treated at least four hours after onset [4]. A commentary in the same journal noted that patients with no light perception at presentation have not responded to any protocol, and that spontaneous partial recovery confounds the uncontrolled case reports in which retrobulbar hyaluronidase has appeared to help [5].
Nothing published since has settled the question. An intervention with a contested mechanism, a difficult technique and no controlled evidence should not be tried for the first time in an aesthetic clinic by someone who has only read about it. It is a procedure for clinicians who perform retrobulbar injections routinely.
What an agreed referral pathway must contain
- A named receiving service. Find out which hospital near you takes acute eye emergencies out of hours, whether they want a call first, and which number reaches the on-call ophthalmologist rather than a switchboard. Post it where the caller can read it with their hands busy.
- A named caller. In a single-handed clinic the injector is also on the phone, reassuring the patient and finding the notes. That does not work, so if you practise alone the plan must say what gets dropped.
- A pre-written handover form. The receiving clinician needs the product, the site, the time of injection and the time symptoms began. A form filled in as events happen beats recall under pressure and survives the transfer better than a verbal account.
- A rule that the patient's report is the finding. A patient who says they cannot see properly outranks anything you can see on the skin. Acting and being wrong costs an unnecessary referral. Waiting to confirm costs what cannot be recovered.
- One spoken rehearsal. Walk through who does what with whoever is in the building, in the time it takes to make coffee. It is the cheapest item on this list and the one most often skipped.
When you compare courses, ask what happens in their teaching when a simulated patient says they cannot see. A good answer involves rehearsal with clinicians who have managed it, so that you have already decided, on an ordinary afternoon, who picks up the telephone.
Read next
- Hyaluronidase: using it in an occlusion, and when not to
- Facial Arteries Vary: Why Landmarks Are Not Guarantees
- Non-Surgical Rhinoplasty: Why This Is the Least Forgiving Region on the Face